TheraRadar
← Back
Data updated: Mar 29, 2026

ACLARIS

DermatologyImmunology
Pharma

ACLARIS is a pharmaceutical company focused on Dermatology, Immunology. Key products include ESKATA.

2017
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 79%
0 drugs Phase 2: 11
Immunology 21%
0 drugs Phase 2: 3

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Dermatology, Immunology
Eli Lilly big-pharma
Immunology, Dermatology
BAUSCH specialty
Dermatology, Immunology
COSETTE other
Dermatology, Immunology
BAUSCH AND LOMB specialty
Dermatology, Immunology